小程序扫码下单
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或者治疗，非药用，非食用。
维多珠单抗
英文名：Vedolizumab
Cas号：943609-66-3
Cas号：943609-66-3
检测信息查询
| 货号 | 规格 | 货期 | 库存 | 价格 | 会员价 | 订购 |
| 13081324921-1mg | 99.64% | 0 | ￥5800 | |||
| 13081324921-5mg | 99.64% | 0 | ￥17600 |
| 别 名 | |
| Cas号 | 943609-66-3 |
| M D L | |
| 分子式 | |
| 分子量 | |
| 产品参数 | Description
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease. IC50 & Target Integrin[1] Storage Please store the product under the recommended conditions in the Certificate of Analysis. |
| 性状 | Vedolizumab是一种靶向α4β7整联蛋白 (integrin) 的人源化单克隆抗体，用来治疗溃疡性结肠炎和克罗恩病。 |
| 贮存 | References [1]. Soler D, et al. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrintherapeutic antibody in development for inflammatory bowel diseases. J Pharmacol Exp Ther. 2009 Sep;330(3):864-75. [2]. Singh H, et al. Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. J Nat Sci Biol Med. 2016 Jan-Jun;7( |
沪公网安备 31012002003054号